comparemela.com
Home
Live Updates
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update : comparemela.com
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update
/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2023 and provided a corporate update....
Related Keywords
United States ,
Australia ,
American ,
Paul Gaglio ,
Jamese Brown ,
Drug Administration ,
Exchange Commission ,
Corporation Nasdaq ,
Twitter ,
Steatohepatitis Consortium ,
Innocoll Pharmaceuticals Ltd ,
Innocoll Pharmaceuticals ,
Earnings Call Today ,
Business Highlights ,
Opinion Leader ,
Brett Fortune ,
American Journal ,
Defeat Alcoholic Steatohepatitis ,
Fast Track Designation ,
New Drug Application ,
Alcohol Associated Hepatitis ,
End Stage Liver Disease ,
Private Securities Litigation Reform Act ,
Durect Corporation ,
Health Care Amp Hospitals ,
Biotechnology ,
Medical Pharmaceuticals ,
Pharmaceuticals ,
Earnings ,
comparemela.com © 2020. All Rights Reserved.